Figure 4.
Metabolism of LY500307 in fibroblasts, HaCaT keratinocytes, and CTCL cell lines. CTCL cells accumulate significantly higher concentrations of LY500307 than normal skin cells. Fibroblasts and HaCaT keratinocytes catabolize intracellular LY-500307 faster than CTCL cell lines. SeAx cells, MyLa cells, HaCaT keratinocytes, and fibroblasts were treated with 10-μM LY-500307 for 0.5, 24, and 48 hours. The concentrations of LY-500307 were measured by LC-MS/MS in the cell pellet (A) and supernatant (B). Data are shown as means with SD (n = 3-4). ∗P < .05; ∗∗P < .01; # indicates significant difference compared with 24 hours.

Metabolism of LY500307 in fibroblasts, HaCaT keratinocytes, and CTCL cell lines. CTCL cells accumulate significantly higher concentrations of LY500307 than normal skin cells. Fibroblasts and HaCaT keratinocytes catabolize intracellular LY-500307 faster than CTCL cell lines. SeAx cells, MyLa cells, HaCaT keratinocytes, and fibroblasts were treated with 10-μM LY-500307 for 0.5, 24, and 48 hours. The concentrations of LY-500307 were measured by LC-MS/MS in the cell pellet (A) and supernatant (B). Data are shown as means with SD (n = 3-4). ∗P < .05; ∗∗P < .01; # indicates significant difference compared with 24 hours.

or Create an Account

Close Modal
Close Modal